🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the best dose and side effects of mephalan in tr...
Status
Recruiting
Location
Winship Cancer Institute of Emory University
Start Date
2021-05-20
Trial ID
NCT04483206
Treatments Being Tested
This randomized phase III trial studies 90-yttrium ibritumomab tiuxetan and...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2015-01
Trial ID
NCT02366663
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
CCOP - Scottsdale Oncology Program
Start Date
1994-01
Trial ID
NCT00002548
RATIONALE: Giving CpG 7909 after an autologous stem cell transplant may mak...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2003-09
Trial ID
NCT00369291
Treatments Being Tested
MG may be neonatal, congenital, or autoimmune. Neonatal MG arises from tran...
Status
Terminated
Location
Northwestern University, Feinberg School of Medicine
Start Date
2002-02
Trial ID
NCT00424489
RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer...
Status
Completed
Location
Aurora Presbyterian Hospital
Start Date
1993-05-07
Trial ID
NCT00002514
Treatments Being Tested
This is a study of a regimen of melphalan and autologous stem cells for pat...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2004-04-20
Trial ID
NCT00177047
Treatments Being Tested
A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with B...
Status
Recruiting
Location
Institut Català D'Oncologia - Hospital Germans Trias I Pujol
Start Date
2020-06-01
Trial ID
NCT04378647
It is expected that addition of anti-CD20 antibody - ofatumumab would enhan...
Status
Completed
Location
Dolnośląskie Centrum Transplantacji Komórkowych
Start Date
2011-11
Trial ID
NCT01481272
Evaluate the safety and efficacy of Inaticabtagene autoleucel combined with...
Status
Recruiting
Location
National Institute of Hematology, Chinese Academy of Medical Sciences
Start Date
2024-08-01
Trial ID
NCT06608732
Treatments Being Tested